| 영문 | anaphylaxis | 한글 | 아나필락시스, 과민증 |
|---|---|---|---|
| 설명 | 아나필락시스라는 말은 제 1형 과민반응과 같은 말로 외계의 물질에 대한 면역 반응이 지나치게 항진되어 있는 병적인 상태를 말한다. 면역이란 외부물질에 대한 방어를 목적으로 하는 세포들의 활동을 의미하며, 여기에는 항체의 형성, 세포들의 포식작용(외부에서 들어온 물질을 면역기능을 하는 세포가 잡아먹는 것)등이 포함된다. 항체의 형성은 외부로부터 들어온 물질을 우선 큰포식세포 등이 포식을 하고 이것에 대한 정보를 T-림프구에게 전달하고 T-림프구는 이 정보를 처리하여 집약된 정보를 B-림프구에게 전달하며 이 세포로 하여금 그 물질 에 대한 항체를 생성하게 한다. 항체는 외부의 물질과 정확히 결합하여 외부의 물질의 활성화를 없애는 물질이다. 이렇게 형성된 항체중에서 IgE에 부착될 수 있는, 즉 이미 항체 IgE가 형성된(이렇게 되기 위해서는 그 물질이 이전에 한 번 몸속에 들어 왔어야 한다) 물질이 히스타민 등의 여러 물질이 나오게 되고 이런 물질들에 의해서 생기는 여러 가지 신체에 해로운 반응이 생겨난다. 그래서 필요 이상으로 과민한 이러한 형태의 면역작용을 거치는 반응을 아니필락시스라 한다. |
||
| SRS-A | Slow Reacting Substance of Anaphylaxis |
|---|---|
| ASA | acetylsalicylic acid; active systemic anaphylaxis; Adams-Stokes attack; American Society of Anesthes... |
| BK-A | basophil kallikrein of anaphylaxis |
| ECFA, ECF-A | eosinophilic chemotactic factor of anaphylaxis |
| PAF-A | platelet-activating factor of anaphylaxis |
| ACA | Active cutaneous anaphylaxis |
|---|---|
| IA | Idiopathic Anaphylaxis |
| PCA | Passive Cutaneous Anaphylaxis |
| SRS-A | Slow Reacting Substance of Anaphylaxis |
| ASA | active systemic anaphylaxis |
| heterologous | <molecular biology> Derived from the tissues or DNA of a different species. Compare: autologous, homologous. (18 Nov 1997) |
|---|---|
| heterologous antiserum | An antiserum that reacts with (e.g., agglutinates) certain microorganisms or other complexes of antigens, even though the antiserum was produced by means of stimulation with a different microorganism or antigenic material. See: homologous antiserum. (05 Mar 2000) |
| heterologous desensitization | Stimulation by one agonist which leads to a broad pattern of unresponsiveness to further stimulation by a variety of other agonists. (05 Mar 2000) |
| heterologous graft | <surgery> A surgical graft of tissue from one species onto or into individuals of unlike species, genus or family. Also know as a heteroplastic graft. See: xenotransplantation. (11 May 1997) |
| heterologous insemination | Artificial insemination with semen from a donor who is not the woman's husband. Synonym: donor insemination. Homologous insemination, artificial insemination with the husband's semen. (05 Mar 2000) |
| heterologous protein | A protein that differs from any protein normally found in the organism in question. Synonym: heterologous protein. (05 Mar 2000) |
| heterologous serotype | An antibody that was induced by one antigen and reacts with another antigen. (05 Mar 2000) |
| heterologous stimulus | A stimulus that acts upon any part of the sensory apparatus or nerve tract. (05 Mar 2000) |
| heterologous tumour | A tumour composed of a tissue unlike that from which it springs. (05 Mar 2000) |
| heterologous twins | Dizygotic twins are siblings who have shared a common uterine environment. They are due to fertilization of two different ova by different sperm. Dizygotic twins are also called fraternal twins. (12 Dec 1998) |
| insemination, artificial, heterologous | Human artificial insemination in which the semen used is that of a man other than the woman's husband. (12 Dec 1998) |
| transplantation, heterologous | Transplantation between animals of different species. (12 Dec 1998) |
| active anaphylaxis | Reaction following inoculation of antigen in a subject previously sensitised to the specific antigen, in contrast to passive anaphylaxis. (05 Mar 2000) |
| aggregate anaphylaxis | <pharmacology> As opposed to prophylaxis. A system or treatment that leads to damaging effects on the organism. <immunology> Now reserved for those inflammatory reactions resulting from combination of a soluble antigen with IgE bound to a mast cell that leads to degranulation of the mast cell and release of histamine and histamine like substances, causing localised or global immune reponses. Results in an acute allergic reaction with shortness of breath, rash, wheezing, hypotension. See: hypersensitivity. (18 Nov 1997) |
| anaphylaxis | <pharmacology> As opposed to prophylaxis. A system or treatment that leads to damaging effects on the organism. <immunology> Now reserved for those inflammatory reactions resulting from combination of a soluble antigen with IgE bound to a mast cell that leads to degranulation of the mast cell and release of histamine and histamine like substances, causing localised or global immune reponses. Results in an acute allergic reaction with shortness of breath, rash, wheezing, hypotension. See: hypersensitivity. (18 Nov 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|